Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513572 · ClinicalTrials.gov registry record
Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices
A clinical trial, sponsored by Rhaeos.
- Terminated
- Registry status
- 10
- Enrollment target
NCT06513572: Clinical Trial study, sponsored by Rhaeos.
NCT06513572 is a clinical trial that was terminated before completion, run by Rhaeos. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513572 was terminated before completion, sponsored by Rhaeos.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.
Primary Outcome
Correlation between measurements from flowing shunts, non-flowing shunts, and off-shunt locations.
Interventions
- DEVICE FlowSense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2024-07-27 |
Why NCT06513572 stopped before completion
NCT06513572 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FlowSense is the first listed.
NCT06513572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06513572 about?
NCT06513572 is a clinical study titled "Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices". This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.
What is the current status of trial NCT06513572?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2024-07-25. Estimated completion is 2024-07-27.
What interventions are being tested in trial NCT06513572?
The interventions under investigation include: FlowSense (DEVICE).
Who is sponsoring clinical trial NCT06513572?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI